M. Bertoncelli

Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation.

S. Pileri, B. Falini, E. Sabattini, 1995, Leukemia & lymphoma.

Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study

A. Fontanella, G. Gussoni, M. Campanini, 2016, BMC Infectious Diseases.

Lymphoproliferation in type II mixed cryoglobulinemia.

S. Pileri, E. Sabattini, M. Ballaré, 1995, Clinical and experimental rheumatology.

MACOP-B treatment for advanced stage diffuse large cell lymphoma: a multicenter Italian Study.

A. Levis, A. Gallamini, U. Vitolo, 1989, European journal of cancer & clinical oncology.

Hepatotoxicity of hydroxy-methyl-glutaryl-coenzyme A reductase inhibitors.

M. Campanini, M. Ballaré, M. Porzio, 1992, Minerva gastroenterologica e dietologica.

Hepatitis C virus RNA in the bone marrow of patients with mixed cryoglobulinemia and in subjects with noncryoglobulinemic chronic hepatitis type C.

G. Zehender, G. Monti, F. Saccardo, 1995, The Journal of infectious diseases.

A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion?

M. Brambilla, E. Inglese, M. Ballaré, 1995, Clinical and experimental rheumatology.